AAAAAA
Results:
1-13
|
Results: 13
Authors:
Kageshita, T
Mizuno, M
Ono, T
Matsumoto, K
Saida, T
Yoshida, J
Citation: T. Kageshita et al., Growth inhibition of human malignant melanoma transfected with the human interferon-beta gene by means of cationic liposomes, MELANOMA RE, 11(4), 2001, pp. 337-342
Authors:
Kageshita, T
Kawakami, Y
Ono, T
Citation: T. Kageshita et al., Clinical significance of MART-1 and HLA-A2 expression and CD8+T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients, J DERMA SCI, 25(1), 2001, pp. 36-44
Authors:
Kageshita, T
Funasaka, Y
Ichihashi, M
Wakamatsu, K
Ito, S
Ono, T
Citation: T. Kageshita et al., Tissue factor expression and serum level in patients with melanoma does not correlate with disease progression, PIGM CELL R, 14(3), 2001, pp. 195-200
Authors:
Kageshita, T
Hamby, CV
Ishihara, T
Matsumoto, K
Saida, T
Ono, T
Citation: T. Kageshita et al., Loss of beta-catenin expression associated with disease progression in malignant melanoma, BR J DERM, 145(2), 2001, pp. 210-216
Authors:
Wakasugi, S
Kageshita, T
Ono, T
Citation: S. Wakasugi et al., Metastatic melanoma to the palatine tonsil with a favourable prognosis, BR J DERM, 145(2), 2001, pp. 327-329
Authors:
Kageshita, T
Hamby, CV
Hirai, S
Kimura, T
Ono, T
Ferrone, S
Citation: T. Kageshita et al., alpha(nu)beta(3) expression on blood vessels and melanoma cells in primarylesions; differential association with tumor progression and clinical prognosis (vol 49, pg 314, 2000), CANCER IMMU, 49(9), 2000, pp. 515-515
Authors:
Kageshita, T
Hamby, CV
Hirai, S
Kimura, T
Ono, T
Ferrone, S
Citation: T. Kageshita et al., alpha(v)beta(3) expression on blood vessels and melanoma cells in primary lesions; differential association with tumor progression and clinical prognosis, CANCER IMMU, 49(6), 2000, pp. 314-318
Authors:
Kageshita, T
Hamby, CV
Hirai, S
Kimura, T
Ono, T
Ferrone, S
Citation: T. Kageshita et al., Differential clinical significance of alpha(v)beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes, INT J CANC, 89(2), 2000, pp. 153-159
Authors:
Kageshita, T
Matsui, T
Hirai, S
Fukuda, Y
Ono, T
Citation: T. Kageshita et al., Hypercalcaemia in melanoma patients associated with increased levels of parathyroid hormone-related protein, MELANOMA RE, 9(1), 1999, pp. 69-73
Authors:
Kageshita, T
Yamamoto, A
Yamazaki, N
Ishihara, K
Ono, T
Citation: T. Kageshita et al., Low frequency of neutralizing antibodies against natural interferon-beta during adjuvant therapy for Japanese patients with melanoma, J DERMA SCI, 19(3), 1999, pp. 208-212
Authors:
Suenaga, Y
Katabuchi, H
Okamura, H
Kageshita, T
Ono, T
Citation: Y. Suenaga et al., Increased serum levels of 5-S-cysteinyldopa and intercellular adhesion molecule-1 in a patient with a uterine amelanotic metastasis from a primary vaginal malignant melanoma, GYNECOL ONC, 72(1), 1999, pp. 107-110
Authors:
Tomoda, A
Miike, T
Iwatani, N
Ninomiya, T
Mabe, H
Kageshita, T
Ito, S
Citation: A. Tomoda et al., Effect of long-term melatonin administration on school-phobic children andadolescents with sleep disturbances, CURR THER R, 60(11), 1999, pp. 607-612
Authors:
Kageshita, T
Hirai, S
Ono, T
Hicklin, DJ
Ferrone, S
Citation: T. Kageshita et al., Down-regulation of HLA class I antigen-processing molecules in malignant melanoma - Association with disease progression, AM J PATH, 154(3), 1999, pp. 745-754
Risultati:
1-13
|